O'Melveny Represents Aesthetic Medical International Holdings in its Nasdaq IPO
October 26, 2019
FOR IMMEDIATE RELEASE
NEW YORK —October 26, 2019 — O’Melveny represented Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH), or Aesthetic Medical International, in its US$30 million IPO on the Nasdaq. Aesthetic Medical International offered 2,500,000 ADSs at an initial offering price of US$12.00 per ADS. The total gross proceeds of the offering are expected to be approximately US$34.5 million if the underwriters choose to exercise their over-allotment option in full. Established in 1997 and known as “Peng’ai” in China, Aesthetic Medical International is a leading provider of aesthetic medical services in China. Its treatment centers are spread across 15 cities in mainland China, and it also has presence in Hong Kong and Singapore.
The O’Melveny team was led by partner Ke Geng and included partner Ke Zhu, partner Li Han, counsel Ye Sun, counsel Lillian Cheung, counsel Adam Ajlouni , associates Sydney Ryan and Aaron Xin, trainee solicitor Hilda Leung, and legal consultant Liam Liu. Partner Rob Plesnarski advised on SEC related issues, and partner Luc Moritz and counsel Anita Choi provided tax-related advice.
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at omm.com.
Contact:
Christopher Rieck
O’Melveny & Myers LLP
+1 212 326 2218
crieck@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com